Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RGEN stock: Repligen Corporation

Current Rating
Sell

Previous Rating

Hold/Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$206.01
Market Cap
10.97B
Sector
Health Care
Div. Growth
-
P/E
140.1
P/B
7.11
P/S
25.55
Dividend %
-
P/CF
64.8
P/FCF
297.8
Op. Cash Flow
62.4K
FCF
0.6
Op. Margin
21.80%
Net Margin
18.40%
ROE
6.00%
ROI
4.00%
ROA
4.70%
EPS Growth
220.10%
Current Ratio
2.8
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Sonoma Pharmaceuticals Inc (SNOA) $6.28 - - 15.2M Strong Buy
AngioDynamics, Inc. (ANGO) $26.10 - - 1.04B Strong Buy
Acer Therapeutics Inc (ACER) $2.31 - - 40.9M Strong Buy
Opiant Pharmaceuticals Inc (OPNT) $16.83 - - 60.7M Strong Buy
Natus Medical Inc (NTUS) $24.99 - - 904.4M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More